Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W H Pinover

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Cancer|September 26, 2001
Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniquesE M Horwitz, A L Hanlon, W H Pinover, et al.
The Cancer Journal From Scientific American|June 15, 1999
Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapyG E Hanks, A L Hanlon, W H Pinover, et al.
Radiation Oncology Investigations|May 20, 1999
Is there a subset of patients with PSA > or = 20 ng/ml who do well after conformal beam radiotherapy?O Algan, W H Pinover, A L Hanlon, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2001
Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207)L E Gaspar, K Winter, W I Kocha, et al.
World Journal of Urology|January 1, 1997
Radiation therapy as treatment for stage T1c prostate cancersG E Hanks, A L Hanlon, W H Pinover, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Dose selection for prostate cancer patients based on dose comparison and dose response studiesG E Hanks, A L Hanlon, W H Pinover, et al.
Urology|July 1, 1997
Conformal external beam treatment of prostate cancerG E Hanks, A L Hanlon, T E Schultheiss, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directionsG E Hanks, A L Hanlon, T E Schultheiss, et al.
Urology|July 22, 1999
Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancerJ V Tricoli, D L Winter, A L Hanlon, et al.
Urology|October 13, 2001
Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancerD L Winter, A L Hanlon, S L Raysor, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer|September 26, 2001
Defining the optimal radiation dose with three-dimensional conformal radiation therapy for patients with nonmetastatic prostate carcinoma by using recursive partitioning techniquesE M Horwitz, A L Hanlon, W H Pinover, et al.
The Cancer Journal From Scientific American|June 15, 1999
Survival advantage for prostate cancer patients treated with high-dose three-dimensional conformal radiotherapyG E Hanks, A L Hanlon, W H Pinover, et al.
Radiation Oncology Investigations|May 20, 1999
Is there a subset of patients with PSA > or = 20 ng/ml who do well after conformal beam radiotherapy?O Algan, W H Pinover, A L Hanlon, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2001
Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207)L E Gaspar, K Winter, W I Kocha, et al.
World Journal of Urology|January 1, 1997
Radiation therapy as treatment for stage T1c prostate cancersG E Hanks, A L Hanlon, W H Pinover, et al.
International Journal of Radiation Oncology, Biology, Physics|March 8, 2000
Dose selection for prostate cancer patients based on dose comparison and dose response studiesG E Hanks, A L Hanlon, W H Pinover, et al.
Urology|July 1, 1997
Conformal external beam treatment of prostate cancerG E Hanks, A L Hanlon, T E Schultheiss, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 1998
Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directionsG E Hanks, A L Hanlon, T E Schultheiss, et al.
Urology|July 22, 1999
Racial differences in insulin-like growth factor binding protein-3 in men at increased risk of prostate cancerJ V Tricoli, D L Winter, A L Hanlon, et al.
Urology|October 13, 2001
Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancerD L Winter, A L Hanlon, S L Raysor, et al.
Pageof 3